Stock Fundamentals

AI Research Report

Generate a comprehensive financial analysis report powered by AI

AGEN.US Logo

AGEN.US - Current Price

$4.25

Company Information

▼
Company Name
Agenus Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US00847G8042
CIK: 0001098972
CUSIP: 037032109
Currency: USD
Full Time Employees: 316
Phone: 781 674 4400
Website: https://www.agenusbio.com
Fiscal Year End: December
IPO Date: Feb 04, 2000
Description:

Agenus Inc., a clinical-stage biotechnology company, discovers and develops therapies to activate the body's immune system against cancer and infections in the United States and internationally. It offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops QS-21 Stimulon adjuvant, a saponin-based vaccine adjuvant. The company also develops Balstilimab, a programmed death receptor-1 (PD-1) blocking antibody; AGEN1181, a human Fc-enhanced cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody that is in Phase 2 trials in metastatic colorectal cancer (mCRC), pancreatic cancer, and melanoma; AGEN2373, a CD137 monospecific antibody that is in Phase 1b clinical trial; AGEN1423, a CD73/TGFß TRAP antibody; AGEN1571, an ILT2 monospecific antibody that is in clinical development; and BMS-986442, a TIGIT bispecific antibodies. In addition, it develops INCAGN1876, a GITR agonist; INCAGN2390, a TIM-3 monoclonal antibodies; INCAGN2385, a LAG-3 monospecific antibody; MK-4830, a monospecific antibody targeting ILT4 that is in Phase 2 clinical trial; UGN-301, a zalifrelimab intravesical solution for the treatment of cancers of the urinary tract t; and AGEN1884. The company operates under the Agenus, MiNK, Prophage, Retrocyte Display, and STIMULON trademarks. It has collaborations with Bristol-Myers Squibb Company, Betta Pharmaceuticals Co., Ltd., UroGen Pharma Ltd., Gilead Sciences, Inc., Incyte Corporation, and Merck Sharp & Dohme. The company was formerly known as Antigenics Inc. and changed its name to Agenus Inc. in January 2011. Agenus Inc. was founded in 1994 and is headquartered in Lexington, Massachusetts.

Address:

3 Forbes Road, Lexington, MA, United States, 02421-7305

Directors & Officers

▼
Name Title Year Born
Dr. Garo H. Armen Ph.D. Founder, Executive Chairman & CEO 1953
Ms. Christine M. Klaskin VP of Finance, Principal Financial Officer & Principal Accounting Officer 1966
Dr. Steven J. O'Day M.D., Ph.D. Chief Medical Officer 1961
Dr. Jennifer S. Buell Ph.D. Director and President & CEO of MiNK Therapeutics 1975
Craig Winter Chief Information Officer NA
Mr. Zack Armen Head of Investor Relations & Corporate Development NA
Ms. Stefanie Perna-Nacar Chief Communications & Government Relations Officer NA
Ms. Tracy Mazza Clemente Chief People Officer NA
Mr. Alfred Dadson Chief Manufacturing Officer NA
Dr. Todd Jude Yancey M.D. Member of Advisory Board & Chief Strategic Advisor NA

Shares Statistics

▼
Shares Outstanding: 34.01M
Shares Float: 33.42M
% Insiders: 173.40%
% Institutions: 2,843.30%
Short % Float: 8.23%

Valuation Metrics

▼
Enterprise Value: $175.29M
Trailing P/E: 0.00
Forward P/E: 3.52

Financial Highlights

▼
Market Cap: $144.54M
EBITDA: $-50.28M
PEG Ratio: $0.00
Book Value: $-8.35
Earnings/Share: $-1.57
Profit Margin: -32.92%
Operating Margin: -16.08%
ROA (TTM): -16.66%
ROE (TTM): -1,278.83%
Revenue (TTM): $106.83M
Revenue/Share (TTM): $3.98
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 20.40%

Stock Price History

▼

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

▼

Revenue & Net Income

Operating Expenses

Balance Sheet Overview

Earnings Per Share (EPS)

Earnings History

▼
Date EPS Actual EPS Estimate Difference Surprise %
Sep 30, 2025 -1.16 2.20 N/A -15,291.57%
Jun 30, 2025 -1.00 -0.27 N/A -27,037.04%
Mar 31, 2025 -1.03 -1.98 N/A 4,797.98%
Dec 31, 2024 -2.04 -2.54 N/A 1,974.82%
Sep 30, 2024 -3.08 -2.33 N/A -3,218.88%
Jun 30, 2024 -2.52 -1.44 N/A -7,500.00%
Mar 31, 2024 -3.04 -3.22 N/A 559.01%
Dec 31, 2023 -0.13 -0.05 N/A -16,000.00%
Sep 30, 2023 -0.16 -0.19 N/A 1,578.95%
Jun 30, 2023 -0.20 -0.20 N/A 0.00%
Mar 31, 2023 -0.22 -0.21 N/A -476.19%
Dec 31, 2022 -0.24 -0.22 N/A -909.09%
Sep 30, 2022 -0.19 -0.19 N/A 0.00%
Jun 30, 2022 -0.17 -0.23 N/A 2,608.70%
Mar 31, 2022 -0.19 -0.30 N/A 3,666.67%
Dec 31, 2021 -0.26 -0.16 N/A -6,250.00%
Sep 30, 2021 0.69 0.46 N/A 5,000.00%
Jun 30, 2021 -0.37 -0.24 N/A -5,416.67%
Mar 31, 2021 -0.27 -0.31 N/A 1,290.32%
Dec 31, 2020 -0.20 -0.22 N/A 909.09%
Sep 30, 2020 -0.28 -0.26 N/A -769.23%
Jun 30, 2020 -0.28 -0.27 N/A -370.37%
Mar 31, 2020 -0.31 -0.33 N/A 606.06%
Dec 31, 2019 -0.22 -0.38 N/A 4,210.53%
Sep 30, 2019 -0.33 -0.38 N/A 1,315.79%
Jun 30, 2019 -0.38 -0.33 N/A -1,515.15%
Mar 31, 2019 0.12 -0.29 N/A 14,137.93%
Dec 31, 2018 -0.40 -0.28 N/A -4,285.71%
Sep 30, 2018 -0.29 -0.25 N/A -1,600.00%
Jun 30, 2018 -0.24 -0.40 N/A 4,000.00%
Mar 31, 2018 -0.42 -0.30 N/A -4,000.00%
Dec 31, 2017 -0.35 -0.29 N/A -2,068.97%
Sep 30, 2017 -0.37 -0.34 N/A -882.35%
Jun 30, 2017 -0.32 -0.37 N/A 1,351.35%
Mar 31, 2017 -0.18 -0.27 N/A 3,333.33%
Dec 31, 2016 -0.30 -0.30 N/A 0.00%
Sep 30, 2016 -0.47 -0.30 N/A -5,666.67%
Jun 30, 2016 -0.33 -0.34 N/A 294.12%
Mar 31, 2016 -0.37 -0.22 N/A -6,818.18%
Dec 31, 2015 -0.18 -0.17 N/A -588.24%
Sep 30, 2015 -0.16 -0.16 N/A 0.00%
Jun 30, 2015 -0.53 -0.15 N/A -25,333.33%
Mar 31, 2015 -0.28 -0.01 N/A -270,000.00%
Dec 31, 2014 -0.41 -0.16 N/A -15,625.00%
Sep 30, 2014 -0.13 -0.15 N/A 1,333.33%
Jun 30, 2014 -0.12 -0.16 N/A 2,500.00%
Mar 31, 2014 -0.01 -0.13 N/A 9,230.77%
Dec 31, 2013 -0.16 -0.24 N/A 3,333.33%
Sep 30, 2013 -0.24 -0.26 N/A 769.23%
Jun 30, 2013 -0.40 -0.22 N/A -8,181.82%
Mar 31, 2013 -0.35 -0.22 N/A -5,909.09%
Dec 31, 2012 -0.23 -0.24 N/A 416.67%
Sep 30, 2012 -0.24 -0.29 N/A 1,724.14%
Jun 30, 2012 -0.31 -0.27 N/A -1,481.48%
Mar 31, 2012 0.29 -0.28 N/A 20,357.14%
Dec 31, 2011 -0.29 -0.28 N/A -357.14%
Sep 30, 2011 -0.28 -0.28 N/A 0.00%
Jun 30, 2011 -0.30 -0.30 N/A 0.00%
Mar 31, 2011 -0.30 -0.24 N/A -2,500.00%
Dec 31, 2010 -0.18 -0.30 N/A 4,000.00%
Sep 30, 2010 -0.36 -0.36 N/A 0.00%
Jun 30, 2010 -0.30 -0.30 N/A 0.00%
Mar 31, 2010 -0.60 -0.36 N/A -6,666.67%
Dec 31, 2009 0.12 -0.54 N/A 12,222.22%
Sep 30, 2009 -0.78 -0.66 N/A -1,818.18%
Jun 30, 2009 -20.16 N/A N/A N/A
Mar 31, 2009 -0.84 -0.72 N/A -1,666.67%
Dec 31, 2008 0.48 -0.96 N/A 15,000.00%
Sep 30, 2008 -1.02 -1.08 N/A 555.56%
Jun 30, 2008 -1.14 -1.08 N/A -555.56%
Mar 31, 2008 -1.20 -0.84 N/A -4,285.71%
Dec 31, 2007 -0.96 -1.38 N/A 3,043.48%
Sep 30, 2007 -1.50 -1.38 N/A -869.57%
Jun 30, 2007 -1.32 -1.32 N/A 0.00%
Mar 31, 2007 -23.22 N/A N/A N/A
Dec 31, 2006 -1.56 -1.26 N/A -2,380.95%
Sep 30, 2006 -1.44 -1.34 N/A -746.27%
Jun 30, 2006 -1.86 -1.42 N/A -3,098.59%
Mar 31, 2006 -2.16 -2.10 N/A -285.71%
Dec 31, 2005 -2.34 -2.58 N/A 930.23%
Sep 30, 2005 -2.28 -2.58 N/A 1,162.79%
Jun 30, 2005 -2.82 -2.44 N/A -1,557.38%
Mar 31, 2005 -2.40 -2.35 N/A -212.77%
Dec 31, 2004 -2.28 -2.40 N/A 500.00%
Sep 30, 2004 -2.46 -2.59 N/A 501.93%
Jun 30, 2004 -0.42 -2.02 N/A 7,920.79%
Mar 31, 2004 -2.46 -2.48 N/A 80.65%
Dec 31, 2003 -2.76 -2.59 N/A -656.37%
Sep 30, 2003 -2.70 -2.43 N/A -1,111.11%
Jun 30, 2003 -2.52 -2.40 N/A -500.00%
Mar 31, 2003 -2.16 -2.82 N/A 2,340.43%
Dec 31, 2002 -2.94 -2.59 N/A -1,351.35%
Sep 30, 2002 -2.40 -2.42 N/A 82.64%
Jun 30, 2002 -2.40 -2.30 N/A -434.78%
Mar 31, 2002 -2.22 -2.22 N/A 0.00%
Dec 31, 2001 -2.40 -2.34 N/A -256.41%
Sep 30, 2001 -2.40 -1.92 N/A -2,500.00%
Jun 30, 2001 -1.86 -1.71 N/A -877.19%
Mar 31, 2001 -1.62 -1.62 N/A 0.00%
Dec 31, 2000 -3.72 -1.62 N/A -12,962.96%
Sep 30, 2000 -1.14 -1.32 N/A 1,363.64%
Jun 30, 2000 -1.20 -1.11 N/A -810.81%
Mar 31, 2000 -1.14 -1.08 N/A -555.56%

Balance Sheet (Yearly)

▼
Date Cash Total Debt Total Assets Total Liabilities Total Equity
2024-12-31 $40.44M $N/A $226.27M $532.70M $-326.38M
2023-12-31 $76.11M $N/A $313.91M $462.30M $-160.33M
2022-12-31 $178.67M $N/A $413.56M $468.46M $-61.28M
2021-12-31 $291.93M $N/A $465.96M $418.05M $34.44M
2020-12-31 $99.87M $N/A $214.51M $426.01M $-203.67M
2019-12-31 $61.81M $N/A $155.34M $386.67M $-225.36M
2018-12-31 $53.05M $N/A $136.40M $310.95M $-172.47M
2017-12-31 $60.19M $N/A $138.40M $214.22M $-75.82M
2016-12-31 $76.44M $N/A $156.99M $196.11M $-39.13M
2015-12-31 $171.67M $N/A $242.23M $171.50M $70.73M
2014-12-31 $40.22M $N/A $74.53M $51.51M $23.02M
2013-12-31 $27.35M $N/A $34.84M $39.32M $-4.48M
2012-12-31 $21.47M $N/A $34.67M $46.69M $-17.60M
2011-12-31 $10.75M $N/A $19.81M $40.64M $-26.41M
2010-12-31 $19.78M $N/A $30.91M $45.61M $-14.71M
2009-12-31 $20.07M $N/A $45.87M $62.85M $-16.98M
2008-12-31 $24.47M $N/A $56.95M $80.86M $-23.92M
2007-12-31 $14.48M $N/A $44.54M $91.60M $-47.06M
2006-12-31 $24.22M $N/A $72.95M $90.35M $-17.39M
2005-12-31 $33.22M $N/A $104.15M $72.25M $31.90M
2004-12-31 $15.98M $N/A $133.06M $26.61M $106.44M
2003-12-31 $57.21M $N/A $140.08M $34.83M $105.25M
2002-12-31 $33.13M $N/A $89.06M $11.31M $77.76M
2001-12-31 $60.87M $N/A $93.55M $17.62M $75.93M
2000-12-31 $96.14M $N/A $127.97M $11.26M $116.70M
1999-12-31 $46.40M $N/A $56.00M $4.30M $51.70M

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Feb 15, 2024 N/A N/A N/A N/A N/A N/A
Oct 16, 2023 N/A N/A N/A N/A N/A N/A
Oct 12, 2023 N/A N/A N/A N/A N/A N/A
Oct 04, 2023 N/A N/A N/A N/A N/A N/A
Aug 28, 2023 N/A N/A N/A N/A N/A N/A
Aug 24, 2023 N/A N/A N/A N/A N/A N/A
May 10, 2023 N/A N/A N/A N/A N/A N/A
May 05, 2023 N/A N/A N/A N/A N/A N/A
May 03, 2023 N/A N/A N/A N/A N/A N/A

Watchlist

0

No stocks in watchlist